Market Cap: $31.78B
HI
Huntington Bancshares Incorporated
HBAN
NASDAQ (NASDAQ Global Select)USD
Market Cap: $31.78B
Huntington Bancshares (Ticker: HBAN) has strategically declared a quarterly cash dividend for its Series I Non-Cumulative Perpetual Preferred Stock, reflecting the company's commitment to shareholders…
Huntington National Bank announces a significant business partnership with the University of Michigan, positioning itself as the official consumer bank for the university community. This collaboration…
Huntington Bancshares Approves Quarterly Cash Dividends for Preferred Stocks Huntington Bancshares Incorporated, a significant player in the Midwest banking industry, announces the declaration of quar…
Huntington Bancshares Positions Itself for Regulatory Success in Biopharmaceutical Innovation Huntington Bancshares faces a transformative period following a significant change in its leadership, part…
Huntington Bancshares Seizes Opportunity in Gene Therapy Development Huntington Bancshares is navigating a transformative phase following the departure of a key executive, which has led to a significa…
New Leadership Sparks Hope for Innovative Huntington's Disease Therapy at Huntington Bancshares Huntington Bancshares experiences a significant transformation, marked by the departure of a key executi…
FDA Calls for Rigorous Trials: A Setback for UniQure’s Huntington’s Disease Therapy The U.S. Food and Drug Administration (FDA) intensifies scrutiny on uniQure N.V.’s experimental gene therapy aimed a…
Advancements in Gene Therapy: uniQure's Promising Fourth Quarter The recent fourth-quarter financial results from uniQure N.V. underscore the growing potential of gene therapy in treating rare disease…
Potential Breakthrough in Huntington's Disease Treatment: Skyhawk Therapeutics Seeks Provisional Approval in Australia Skyhawk Therapeutics, Inc., a biotechnology company dedicated to developing innov…
Skyhawk Therapeutics Advances Treatment for Huntington’s Disease with Provisional Approval Pathway Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company, has made significant strides in t…
Huntington Bancshares Maintains Steady Dividend Amidst Strong Financial Position Huntington Bancshares Incorporated, a prominent regional bank holding company based in Columbus, Ohio, reaffirms its co…
Huntington Bancshares Navigates Market Shifts Amid Leadership Changes in Retail Sector In a challenging economic landscape characterized by fluctuating stock performances and shifting consumer behavio…
Huntington Bancshares Navigates Market Shifts Amid Economic Developments Huntington Bancshares finds itself amid a complex economic landscape characterized by significant market rotations and evolving…
Huntington Bancshares Focuses on Leadership and Strategic Growth Amidst Market Turbulence Huntington Bancshares navigates a challenging economic landscape marked by shifting market dynamics and consum…
Huntington Bancshares: A Beacon of Confidence Amidst Mixed Financial Sector Performance In the current climate of the financial sector, Huntington Bancshares stands out as a symbol of resilience and o…
Huntington Bancshares: Resilience Amidst Mixed Financial Sector Performance Huntington Bancshares stands out in the current financial landscape, which is characterized by mixed earnings reports from m…
Innovative Therapeutics Target Huntington's Disease: A Strategic Development in Neurology LoQus23 Therapeutics Ltd, a biotechnology firm based in Cambridge, England, has made a significant stride in t…
Innovative Approaches to Huntington's Disease: The Promise of LQT-23 LoQus23 Therapeutics Ltd, a biotechnology firm based in Cambridge, England, announces a significant development in the fight agains…
Innovative Advances in Huntington's Disease Treatment Resonate with Biotechnology Developments In a notable advancement for Huntington's Disease (HD) treatment, LoQus23 Therapeutics Ltd, a biotechnolo…
Investor Sentiment Shifts for Huntington Ingalls Industries Huntington Ingalls Industries Inc. (HII) experiences a notable decrease in short interest, dropping by 16.02% since the last report. Current…
Investor Sentiment Shifts for Huntington Ingalls Industries Amid Decrease in Short Interest Huntington Ingalls Industries Inc., a prominent player in the defense and shipbuilding sector, experiences a…
Huntington Bancshares and Cadence Bank Join Forces: A New Era in Regional Banking Huntington Bancshares Incorporated and Cadence Bank have received the green light from the Office of the Comptroller o…
Huntington and Cadence Merger: A Strategic Move for Enhanced Market Presence Huntington Bancshares Incorporated and Cadence Bank's recent announcement of their merger marks a significant step within t…
Understanding Luxury Real Estate: A Holistic Approach In the competitive landscape of real estate, particularly in Huntington, West Virginia, understanding the essence of luxury is paramount for both…
Huntington National Bank Appoints Marc Dizard as Chief Investment Officer to Enhance Wealth Management Huntington National Bank announces the appointment of Marc Dizard as the new Chief Investment Off…